Management of ocular inflammation and pain using novel insert

ICMYI: Dr. Tyson shares his pearls using the dexamethasone 0.4 mg insert (Dextenza, Ocular Therapeutix).

Sydney Tyson, MD, shares the take-home message from the presentation he delivered at the 2019 American Society of Cataract and Refractive Surgery meeting: "Management of Ocular Inflammation and Pain Following Cataract Surgery with Dexamethasone 0.4 mg Insert (Dextenza, Ocular Therapeutix)."

Related Content:

ASCRSCataract
Patricia Piers, PhD, discusses a career of innovation in ophthalmology, looks to future
Visual outcomes after secondary IOL implantation in aphakic children
Harrow and iOR Partners expand national product supply agreement